Practical interest of in vivo reflectance confocal microscopy quantification of cutaneous vascular flow during iloprost treatment

C. Jaffelin, E. Cinotti, J. Perrot, B. Labeille, F. Cambazard, L. Tognetti, P. Rubegni, J. Pittet
{"title":"Practical interest of in vivo reflectance confocal microscopy quantification of cutaneous vascular flow during iloprost treatment","authors":"C. Jaffelin, E. Cinotti, J. Perrot, B. Labeille, F. Cambazard, L. Tognetti, P. Rubegni, J. Pittet","doi":"10.1109/MeMeA.2016.7533790","DOIUrl":null,"url":null,"abstract":"Introduction: iloprost is a recommended treatment for several vascular diseases such as severe Raynaud's syndrome and digital ulcers in Systemic Sclerosis (SS). In vivo reflectance confocal microscopy (RCM) is a non-invasive imaging tool that can evaluate cutaneous microcirculation. The goal of this study was to observe, in real time, the effect of iloprost on cutaneous microcirculation by using RCM. Material and method: Five patients with microvascular diseases that needed iloprost were included. Administration speed started at 0.5 ng/kg/min until the maximum tolerated dosage. Recordings of capillary flow were done using RCM before treatment and at each change in the drug dosage. Results: The blood flow of the five patients demonstrated a significant increase from the dosage of 0.5 ng/kg/min. This significant variation did not exist at higher dosage. Discussion: This study suggests a precocious effect of iloprost in increasing the cutaneous vascular flow; this effect was not enhanced at higher drug dosage. Monitoring cutaneous capillary flow by in vivo RCM could then be of interest in optimizing iloprost dosage. This procedure will likely reduce the side effects of iloprost that are dose-dependent.","PeriodicalId":221120,"journal":{"name":"2016 IEEE International Symposium on Medical Measurements and Applications (MeMeA)","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2016 IEEE International Symposium on Medical Measurements and Applications (MeMeA)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/MeMeA.2016.7533790","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: iloprost is a recommended treatment for several vascular diseases such as severe Raynaud's syndrome and digital ulcers in Systemic Sclerosis (SS). In vivo reflectance confocal microscopy (RCM) is a non-invasive imaging tool that can evaluate cutaneous microcirculation. The goal of this study was to observe, in real time, the effect of iloprost on cutaneous microcirculation by using RCM. Material and method: Five patients with microvascular diseases that needed iloprost were included. Administration speed started at 0.5 ng/kg/min until the maximum tolerated dosage. Recordings of capillary flow were done using RCM before treatment and at each change in the drug dosage. Results: The blood flow of the five patients demonstrated a significant increase from the dosage of 0.5 ng/kg/min. This significant variation did not exist at higher dosage. Discussion: This study suggests a precocious effect of iloprost in increasing the cutaneous vascular flow; this effect was not enhanced at higher drug dosage. Monitoring cutaneous capillary flow by in vivo RCM could then be of interest in optimizing iloprost dosage. This procedure will likely reduce the side effects of iloprost that are dose-dependent.
在伊洛前列素治疗期间,体内反射共聚焦显微镜对皮肤血管流量定量的实际意义
简介:伊洛前列素是几种血管疾病的推荐治疗药物,如严重雷诺综合征和系统性硬化症(SS)中的数字溃疡。体内反射共聚焦显微镜(RCM)是一种评估皮肤微循环的非侵入性成像工具。本研究的目的是通过RCM实时观察伊洛前列素对皮肤微循环的影响。材料与方法:纳入5例需要伊洛前列素治疗的微血管疾病患者。起始给药速度为0.5 ng/kg/min,直至最大耐受剂量。在治疗前和每次药物剂量变化时,用RCM记录毛细血管流量。结果:从0.5 ng/kg/min剂量开始,5例患者血流量明显增加。在较高的剂量下,这种显著的变化不存在。讨论:这项研究表明伊洛前列素在增加皮肤血管流量方面具有早熟作用;在较高的药物剂量下,这种效果没有增强。通过体内RCM监测皮肤毛细血管流量可以优化伊洛前列素的剂量。这种方法可能会减少依洛前列素剂量依赖性的副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信